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 Summary 
In epithelial tissues, cells expressing oncogenic Ras (hereafter RasV12 cells) 
are detected by normal neighbours and as a result are often extruded from the tissue 
[1-6]. RasV12 cells are eliminated apically, suggesting that extrusion may be a tu-
mour suppressive process. Extrusion depends on E-cadherin-based cell-cell adhesions 
and signalling to the actin-myosin cytoskeleton [2, 6]. However, the signals underly-
ing detection of the RasV12 cell and triggering extrusion are poorly understood. Here, 
we identify differential EphA2 signalling as the mechanism by which RasV12 cells 
are detected in epithelial cell sheets. Cell-cell interactions between normal cells and 
RasV12 cells trigger ephrin-A-EphA2 signalling, which induces a cell repulsion re-
sponse in RasV12 cells. Concomitantly, RasV12 cell contractility increases in an 
EphA2-dependent manner. Together, these responses drive the separation of RasV12 
cells from normal cells. In the absence of ephrin-A-EphA2 signals, RasV12 cells inte-
grate with normal cells and adopt a pro-invasive morphology. We also show that Dro-
sophila Eph (DEph) is detected in segregating clones of RasV12 cells and is function-
ally required to drive segregation of RasV12 cells in vivo, suggesting that our in vitro 
findings are conserved in evolution. We propose that expression of RasV12 in single 
or small clusters of cells within a healthy epithelium creates ectopic EphA2 bounda-
ries, which drive the segregation and elimination of the transformed cell from the tis-
sue. Thus, deregulation of Eph/ephrin would allow RasV12 cells to go undetected and 
expand within an epithelium.  
 
  
 Results and Discussion 
Based on our previous findings [2], we hypothesised that extrusion of RasV12 
cells is triggered by cell-cell signals at the RasV12-normal interface. To identify these 
signals, we designed the ‘cell confrontation assay’ in order to amplify the interface 
between RasV12 and normal epithelial cells, and used Madin-Darby canine kidney 
(MDCK) epithelial cell culture systems, expressing GFP-tagged, constitutively active, 
oncogenic Ras (RasV12) in a tetracycline/doxycycline-inducible manner [2]. Normal 
or GFP-RasV12 cells were seeded into one of two compartments of a cell culture in-
sert, separated by a fixed gap (Figure S1A), similar to [7]. After removing the culture 
insert, cells migrated to close the gap; opposing cells collided and cell-cell interaction 
occurred between marginal cells. Live cell imaging experiments revealed that upon 
collision with normal cells, marginal GFP-RasV12 cells collapsed (Figure S1B) and 
were repulsed backwards, while normal cells continued to migrate forward (Figure 
1A, 1B, R:N TetON; Movie S1). At 21-30 h post-collision, RasV12 cells had tightly 
packed and separated from normal cells by a distinct and visible border (Figure 1A). 
These phenomena only occurred when GFP-RasV12 was induced in one population 
of cells (Figure 1B, R:N TetOFF). In contrast, when two opposing sheets of GFP-
RasV12 cells collided, both populations stopped migrating (Figure 1B, R:R TetON; 
Movie S2) and fused to form a monolayer (Figure 1A). In the absence of cells in the 
second compartment, GFP-RasV12 cells continued to migrate forward into free space 
(Figure 1B, R:No cells). Single-cell tracking analyses confirmed that upon collision 
with normal cells, RasV12 cells (either at the margin or further behind the leading 
edge) were repulsed backwards with the same direction (Figure S1C; Movie S3). In 
contrast, when RasV12 cells collided with RasV12 cells, cell migration lacked direc-
tionality (Figure S1C; Movie S3). Thus, upon collision with normal cells, RasV12 
cells display cell repulsion, are triggered to migrate backwards and avoid intermin-
gling with normal cells.  
Following collision with normal cells, RasV12 cells rapidly adopted a contrac-
tile morphology. We measured changes in RasV12 cell area as readout for cell con-
tractility, and found that RasV12 cell area significantly decreased following collision 
with normal cells but not with RasV12 cells (Figure 1C). This decrease was observed 
in marginal RasV12 cells (row 1) and in RasV12 cells positioned further behind the 
collision interface (+11; Figure S1D). Hence, as leading RasV12 cells are repulsed, 
 RasV12 cells behind the margin become compressed. In contrast, RasV12 cells collid-
ing with RasV12 cells maintained a constant cell area (Figure S1D).  
Consistent with our previous findings [2], we observed that F-actin accumu-
lated specifically at cell-cell contacts between RasV12 cells that had collided with 
normal cells (Figure 1D). Moreover, neighbouring RasV12 cells positioned behind the 
collision interface and not in direct contact with normal cells, also accumulated F-
actin at cell-cell contacts over time (Figure 1E, S1E, S1F, S1I). Inhibition of myosin-
II or Src family kinase (SFK) pathways reduced RasV12 contractility (Figure S1G). 
Inhibition of SFK but not myosin-II, significantly decreased RasV12 cell repulsion 
(Figure S1H). Indeed, collision with normal cells triggered RasV12 cells to actively 
migrate backwards, independent of myosin-II activity (Movie S4), similar to [8]. 
However, phosphorylated myosin light chain (pMLC) was detected at higher levels 
specifically in RasV12 cells that had collided with normal cells (Figure S1I). Alt-
hough we cannot rule out that migrating normal cells also compress RasV12 cells via 
processes that are myosin-II-independent, our findings indicate a role for myosin-II 
activity in RasV12 cell repulsion. Finally, cell repulsion did not occur when RasV12 
cells collided with E-cadherin-depleted cells (Distance = 0 Pm, n = 2). Here RasV12 
cell area was more comparable to that of RasV12 cells in a monolayer (Figure 1C). 
Moreover, RasV12 cells and E-cadherin-depleted cells separated via an irregular in-
terface (Figure 1F). Thus, upon collision with normal cells RasV12 cells contract and 
separate via a process that is dependent on E-cadherin-based cell-cell adhesion. Cru-
cially, these experiments demonstrate that similar phenomena occur in RasV12 cells 
at the single-cell [2] and multicellular level following interactions with normal cells 
and a dependence on specific signalling proteins is required in both contexts.  
Eph-ephrin signalling regulates cell repulsion and cell segregation; processes 
that prevent cell mixing and drive boundary formation during tissue development and 
maintenance [9]. Similar to previous reports [10, 11], we found that RasV12 cells ex-
pressed EphA2 mRNA (Figure S2A) and protein (Figure S2B) at elevated levels 
compared to normal cells. Expression of EphA2 protein was MEK-ERK-dependent 
(Figure S2B). MEK-ERK signalling was also required to drive RasV12 cell extrusion 
[2], changes in cell area (Figure S1G) and cell repulsion (Figure S1H). Therefore, we 
tested whether Eph-ephrins were necessary to drive RasV12 cell repulsion. We first 
performed cell confrontation assays in the presence of soluble, recombinant ephrin-Fc 
 ligands. We reasoned that soluble ligands would interfere with endogenous Eph-
ephrin signalling, similar to [12-14]. Repulsion of RasV12 cells from normal cells 
was significantly inhibited in the presence of ephrin-A1-Fc, -A4-Fc (Figure S2C), 
whereas addition of ephrin-B ligands had no effect (Figure S2C). Addition of ephrin-
A1, -A4 also significantly reduced RasV12 cell contractility (Figure S2D) and pro-
moted cell intermingling at RasV12-normal cell interfaces (Figure S2E). The inhibito-
ry effects of long-term treatment with ephrin-A ligands may be due to EphA2 down 
regulation from the cell surface ([15]; data not shown). Together, these results suggest 
a requirement of EphA family members in RasV12 cell responses following interac-
tion with normal cells. Both normal and RasV12 cell lines also expressed EphA1, 
ephrin-A1 and -A4 at similar mRNA levels (Figure S2A). Given that EphA2 is a tran-
scriptional target of Ras-MAPK signaling [10] we focused on the functional role of 
EphA2 in RasV12-normal cell-cell interaction.  
In general, binding of ephrin ligand triggers Eph receptor clustering and acti-
vation by phosphorylation on conserved tyrosine residues [16, 17]. We detected ele-
vated levels of phosphorylated EphA2 (Y594) in clusters of RasV12 cells surrounded 
by normal cells (Figure S3A), and in RasV12 cells that had immediately collided 
with, and been repulsed by normal cells (Figure 1G). The intensity of phosphorylated 
EphA2 was significantly higher at the RasV12-normal interface (Figure S3B), 
demonstrating that activation of EphA2 is specifically occurring upon cell-cell inter-
action. Phosphorylated EphA2 was also detected at significantly higher levels at cell-
cell contacts between RasV12 cells within a cluster (Figure S3B; S3F). 
To test the functional role of EphA2, we established two GFP-RasV12 cell 
lines that constitutively expressed independent shRNA constructs targeting EphA2 
(shRNA-1 or -2) as well as scramble control (Figure S3C). When cultured with nor-
mal cells at 1:100 ratios, EphA2-depleted RasV12 cells no longer clustered but ap-
peared flat and spread (Figure 2A). As expected, we did not detect elevated levels of 
phosphorylated EphA2 in EphA2 depleted cells (Figure 2A). To quantify the change 
in cell morphology, we measured the distance between the centre of nuclei of neigh-
bouring cells in direct contact (inter-nuclear distance, IND; Figure 2B). When sur-
rounded by normal cells, RasV12 cells depleted of EphA2 had a significantly higher 
IND compared to RasV12 cells expressing scramble shRNA or parental RasV12 cells 
(Figure 2C), and this was more comparable to the IND value of RasV12 cells in a 
monolayer (Figure 2C). In confrontation assays with normal cells, RasV12 cells de-
 pleted of EphA2 were repulsed less efficiently (Figure 2D) and did not decrease in 
cell area (Figure 2E), independent of their distance to the collision margin (Figure 
S1D). This demonstrates that EphA2 is functionally required to induce the contraction 
of RasV12 cells that are both in direct contact with normal cells and further behind 
the collision interface. Moreover, quantification of the linearity of the border between 
cells ([18]; Figure 2F), indicated that depletion of EphA2 in RasV12 cells promotes 
local intermingling of RasV12 cells and normal cells at the cell-cell interface. Inter-
estingly, RasV12 cells depleted of EphA2 formed large basal protrusions at the inter-
face with normal cells (Figure 2A, 2G, 2H), indicative of a pro-invasive morphology, 
also reported in [2]. F-actin did not accumulate at cell-cell contacts between RasV12 
cells depleted of EphA2, either when present in normal monolayers at 1:100 ratios 
(Figure 2G), or following collision in confrontations assays (Figure 2H; S1E, bottom 
panels). Using established assays [1-5], we found that RasV12 cells depleted of 
EphA2 were apically extruded at a significantly lower frequency than controls (Figure 
2I). Together, our data demonstrate that EphA2 expressed on RasV12 cells is activat-
ed by direct cell-cell interaction with normal cells to induce repulsion and contraction 
of RasV12 cells, and promote the separation of RasV12 and normal cells. Moreover, 
EphA2 is required to induce the contraction and clustering of juxtaposed RasV12 cells 
that are not in direct contact with normal cells.  
As signalling via SFK and myosin-II are required for RasV12 cell contractility 
(Figure S1G) and extrusion [2], we asked whether these signals act downstream of 
EphA2 in RasV12 cells. Phosphorylated (Y416) active Src was detected at elevated 
levels specifically in RasV12 cells surrounded by normal cells but was absent in 
RasV12 cells-depleted of EphA2 (Figure S3D, S3F). In confrontation assays with 
normal cells, the level of pMLC was reduced in RasV12 cells depleted of EphA2 
(Figure S3G). Together these data suggest that SFK and myosin-II are activated 
downstream of EphA2 in RasV12 cells following interaction with normal cells. 
We next explored the requirement of ephrin-A ligands for RasV12 cell repul-
sion. Since normal cells express ephrin-A1 and -A4 ([11]; Figure S2A), we focused 
on examining the role of these specific ligands, firstly by using the cell confrontation 
assay. We used preclustered ephrin-A1-Fc/-A4-Fc (or Fc alone) to coat one compart-
ment of the cell confrontation assay, and seeded RasV12 or normal cells in the other 
compartment in a modified stripe assay [19]. Preclustered recombinant ephrin-Fc pro-
teins can induce Eph receptor clustering and activate signalling [20]. We found that 
 both RasV12 and normal cells migrated over Fc proteins (Figure 3A), but failed to 
migrate over ephrin-A1-Fc ligands (Figure 3A), indicating that both cell populations 
are contact-inhibited by ephrin-A1 ligands. RasV12 cells, and to lesser extent normal 
cells, were also contact inhibited by ephrin-A4 ligands (Figure 3A). These observa-
tions were consistent with the fact that both normal and RasV12 cells express EphA2 
and EphA1 receptors, which specifically bind ephrin-A1 and/or -A4 ligands [21]. 
RasV12 cells depleted of EphA2 migrated (albeit weakly; most likely due to residual 
levels of functional EphA2 expressed on these cells; see Figure S3C) over stripes of 
ephrin-A1-Fc or –A4-Fc (Figure 3B), suggesting that efficient contact inhibition re-
quires EphA2.  
We predicted that upon interaction with ephrin-A ligands RasV12 cells are al-
so triggered to cluster. To test this, we first seeded GFP-RasV12 cells sparsely (and in 
the presence of tetracycline/doxycycline) in order to promote cell scattering ([22]; 
Figure 3D, top panels), before treating the cells with preclustered Fc proteins. Stimu-
lation with ephrin-A-Fc ligands induced RasV12 cells to decrease in cell area, tightly 
cluster and increase E-cadherin-based cell-cell adhesion between cells (Figure 3C). 
Cells treated with Fc protein appeared similar to untreated cells (compare Figure 3C 
to 3D). Consistently, RasV12 cells expressing EphA2 shRNA (and not scramble 
shRNA) did not alter cell morphology or cell-cell adhesion following stimulation with 
ephrin-A-Fc proteins (Figure 3D). Next, we tested whether ephrin-A ligands endoge-
nously expressed on normal cells activate EphA2 expressed on RasV12 cells. We first 
treated normal cells with the enzyme phosphatidylinositol-specific phospholipase C 
(PI-PLC) to remove GPI-linked ephrin-A ligands [23], before mixing with RasV12 
cells at 1:100 ratios. Treatment with PI-PLC significantly removed endogenous 
ephrin-A1 from normal cells (> 80%), which remained depleted up to 24 h after 
treatment (Figure 3E). The level of phosphorylated EphA2 (Y594) was markedly re-
duced in RasV12 cells when surrounded by PI-PLC-treated normal cells compared to 
RasV12 cells surrounded by PBS-treated cells (Figure 3F). RasV12 cells failed to 
tightly cluster in the presence of PI-PLC-treated normal cells (Figure 3G). Notably, 
RasV12 cells in direct contact with PI-PLC-treated normal cells formed large basal 
protrusions (Figure 3F), reminiscent of RasV12 cells depleted of EphA2 (Figure 2A). 
Taken together, our data show that ephrin-A ligands (artificially clustered or mem-
brane bound) activate EphA2 receptor expressed on RasV12 cells and this triggers 
RasV12 cells to contract and cluster with increased intercellular adhesion.  
 Both RasV12 and normal MDCK cell lines express comparable levels of 
ephrin-A ligand mRNA (Figure S2A), total protein (Figure S2F) and cell surface pro-
tein (Figure S2G). However, we never observed cell repulsion between neighbouring 
RasV12 cells. We speculated that a difference in EphA2 expression levels between 
juxtaposed cells was sufficient to drive a repulsion/contractile response in the overex-
pressing cell. Overexpression of EphA2 in RasV12 cells could increase the cells re-
sponsiveness to exogenous ephrin ligands, similar to [24, 25]. To test this we carried 
out both 1:100 coculture, and cell confrontation assays using GFP-RasV12 cells and 
GFP-RasV12 cell lines either expressing EphA2 shRNA (EphA2 KD) or scramble 
shRNA. Since RasV12 EphA2 KD cells expressed low levels of EphA2 protein simi-
lar to normal cells (Figure S3C), we predicted that these cells would behave like nor-
mal cells in these experiments. Using cell confrontation assays, we found that RasV12 
cells separated from RasV12 EphA2 KD cells but intermingled with RasV12 cells ex-
pressing scramble shRNA (Figure 4A). RasV12 cell area significantly decreased fol-
lowing collision with RasV12 EphA2 KD cells (Figure 4B), and RasV12 cells clus-
tered with a significantly lower IND when surrounded by RasV12 EphA2 KD cells 
(Figure 4C). Thus, a difference in EphA2 expression levels between juxtaposed cells 
is sufficient to induce cell repulsion and prevent the intermingling of the opposing 
cells. This in turn triggers contraction and clustering of the EphA2 overexpressing 
cell.  
Cells expressing RasV12 in wing imaginal discs of Drosophila melanogaster 
also cluster [2], with increased DE-cadherin at cell-cell contacts and form uniform 
clones with smooth borders [26], suggesting that similar processes also occur in vivo. 
Indeed, cells co-expressing GFP and RasV12 formed round clusters with smooth bor-
ders that segregate from the surrounding wild-type tissue (39.7%, n = 63; Figure 4D, 
4E). In contrast, clones of cells expressing GFP were irregular in shape and did not 
segregate (0%, n = 102; Figure 4D, 4E). In Drosophila, a single Eph receptor (DEph) 
and ephrin ligand (Dephrin) has been identified, both of which play a role in the de-
veloping nervous system [27, 28]. DEph receptor is also required to maintain the 
straight shape of the anterior/posterior boundary in Drosophila [29]. Using purified 
Dephrin-Fc to probe for DEph expression, we observed a prominent increase in Fc 
staining within segregated RasV12 clusters but not within clones of GFP-expressing 
cells, (60% of segregated clones, n = 25; Figure 4D, 4E). To understand the functional 
significance of this observation, we expressed RNAi constructs to silence DEph in 
 RasV12 cells (Figure S4A, S4B). Depletion of DEph in RasV12 clones reduced the 
formation of round, cyst-like clusters that stably separated from the surrounding wild-
type cells (14%, n = 176). Notably, within this population of RasV12 cells that ap-
peared round and cyst-like, we detected elevated Dephrin-Fc staining (Figure S4C), 
suggesting incomplete knockdown of DEph in these cells. RasV12 clones expressing 
DEph-RNAi and displaying no detectable Dephrin-Fc staining, formed irregularly 
shaped, non-contractile clusters (Figure 4F) and were either aligned in the apico-basal 
axis (45%; Figure 4G), or remained attached to the basal layer (41%; Figure 4G) of 
the epithelium. In parallel, we induced RasV12 clones co-expressing a dominant neg-
ative DEph transgene (DEph DN), which consists of an extracellular and transmem-
brane domain but lacks the intracellular domain, including the kinase domain. Hence, 
DEph DN should bind ligand but would be unable to signal [30]. Similar to the RNAi 
lines, we observed a significant decrease in round, cyst-like clusters of RasV12 cells 
co-expressing DEph DN (12%, n = 103). Instead, the majority of RasV12 cells 
formed irregularly shaped, non-contractile clusters (88%, n = 103) (Figure 4F), which 
aligned in the apico-basal axis of the tissue (Figure 4G). Thus, elevated levels of 
DEph are detected in segregating clones of RasV12 cells and DEph is functionally 
required to drive the segregation of RasV12 cells from wild-type neighbours in vivo.  
Epithelial cells expressing oncogenic v-Src are also extruded from normal 
monolayers via cell-cell interactions [3, 4]. Therefore, we asked whether EphA2 is 
also required for this process. We transiently expressed v-Src (or RasV12) with 
EphA2 dominant negative (EphA2 DN), which lacks a functional intracellular domain 
[31], and scored apical extrusion events. Both RasV12 and v-Src cells were extruded 
at significantly lower levels when cells co-expressed EphA2 DN (Figure S4D), sug-
gesting that EphA2 signalling is also required to drive elimination of v-Src-
transformed cells from epithelial cell sheets.  
In summary, we have found that enhanced expression of EphA2 in RasV12 
cells promotes their detection by and separation from normal neighbours. Cell-cell 
interactions between juxtaposed cells induce EphA2 forward signalling on RasV12 
cells in an ephrin-A ligand-dependent and E-cadherin-dependent manner (Figure S4E, 
(1)). This triggers repulsion and an increase in cell contractility of RasV12 cells in 
direct contact with normal cells (Figure S4E, (2)). In turn, neighbouring RasV12 cells 
that are positioned behind marginal cells and not in direct contact with normal cells 
are triggered to contract in an EphA2-dependent manner (Figure S4E, (3)). We cannot 
 conclusively determine whether this step is ligand-dependent. It is possible that 
EphA2 receptors, which are present at elevated levels on RasV12 cell membranes, 
become mobile [32] to form higher order clusters in the absence of ligand, promoting 
autophosphorylation events [33]. Together with our previous studies, we propose that 
a combination of the initial repulsion signal and the concomitant contractility, pro-
motes the segregation and extrusion of RasV12 cells from normal monolayers. Our 
findings demonstrate that epithelial cells detect and respond to neighbouring cells 
overexpressing Eph both in vitro and in vivo, and it is the steep difference in Eph ex-
pression levels between juxtaposed cells that is critical for this initial response. Intri-
guingly, within monolayers neighbouring RasV12 cells do not display cell repulsion. 
It is possible that inhibitory interactions in cis with coexpressed ephrin-A ligands [23, 
25] occur on RasV12 cells, allowing a fraction of EphA2 receptors free to interact in 
trans with available ephrin-A ligands presented on neighbouring normal cells, similar 
to [24, 25]. Notably, transient expression of EphA2 alone drives apical extrusion of 
single epithelial cells from normal monolayers at low frequencies and at protracted 
time points (11% extruded at 48 h, n = 247 cells), suggesting that additional signals 
may be required for efficient extrusion. Based on our findings, we propose that 
EphA2-mediated repulsion drives the segregation of RasV12 cells from normal cells, 
similar to mechanisms underlying cell segregation at tissue boundaries during devel-
opment [34, 35]. At ectoderm-mesoderm boundaries, local Eph-ephrin signals gener-
ate local increases in myosin-II-dependent contractility, which inhibits cadherin clus-
tering at cell-cell interfaces [36]. Our findings are distinct from S1P-dependent mech-
anisms of extrusion [37, 38]. 
Many Eph receptors are abnormally expressed during tumorigenesis, though 
the significance of this deregulation at the single-cell level is poorly understood. In 
some cancer models, ephrin-expressing normal cells compartmentalise and suppress 
the expansion and invasiveness of Eph-receptor overexpressing cancer cells [39, 40]. 
Compartmentalisation of cancer cells and RasV12 cells requires E-cadherin-based 
cell-cell adhesions ([39]; Figure 1F). It is possible that under pathological conditions 
where E-cadherin-based cell-cell adhesions are disrupted (e.g. inflammation and inju-
ry), EphA2-ephrin-A interactions between RasV12 and normal neighbours would not 
occur, allowing transformed cells to go undetected and spread within an epithelium. 
Whether segregation of abnormal cells by the normal surrounding tissue is tumour 
 promoting or tumour suppressive will require further investigation and may provide 
key insights into early tumorigenesis in epithelial tissues.  
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Figure S1. Upon collision with normal cells, RasV12 cells display cell repulsion 
and increase actin-myosin contractility. Related to Figure 1 and Figure 2. 
(A) Cartoon illustrating the cell confrontation assay. (B) Epifluorescence (top panels) 
and merged bright field images (lower panels) extracted from a representative time-
lapse experiment of a cell confrontation assay of non-labelled normal cells colliding 
with GFP-RasV12 cells. Elapsed time is indicated minutes after collision. White 
arrowhead indicates GFP-RasV12 lamellipod. (C) Representative single cell analyses 
of cell migration. Tracked GFP-RasV12 cells are indicated on the merged images (left 
panels). Right panels show single cell tracks over a 15 h time period post collision 
with opposing cells in cell confrontation assays. Top panels: normal cells confronting 
GFP-RasV12 cells (N:R); Lower panels: GFP-RasV12 cells confronting GFP-RasV12 
cells (R:R). (D) Quantification of GFP-RasV12 cell area (µm2) from each of the first 
ten rows of cells and behind row 11 (11+) from the collision interface using the cell 
confrontation assay. The number of rows available for quantification in rows 11+ 
varied between experiments and was determined by field of view (up to row 14). A 
minimum of 14 cells were analysed per subset of rows. Black bars: GFP-RasV12 cells 
colliding with normal cells (R:N, n = 465 total cells); White bars: GFP-RasV12 cells 
colliding with GFP-RasV12 cells (R:R, n = 150 total cells); Grey bars: GFP-RasV12 
cells constitutively expressing EphA2 shRNA-1 colliding with normal cells (REphA2 
KD:N, n = 327 total cells); Blue bars: GFP-RasV12 cells constitutively expressing 
scramble shRNA colliding with normal cells (RScb:N, n = 500 total cells). Data 
represents mean ±!s.e.m. from three independent experiments; *** p < 0.001; ** p < 
0.01 for R:N versus R:R and RScb:N versus REphA2 KD:N. (E) Confocal images of 
cell confrontation assays of GFP-RasV12 cells colliding with normal cells (upper 
panels), GFP-RasV12 cells colliding with GFP-RasV12 cells (middle panels), GFP-
labelled normal cells colliding with normal cells (lower panels), or GFP-RasV12 cells 
expressing shRNA-1 colliding with normal cells (bottom panels). Cells were fixed at 
19 h (top panels only; ~1-2 h pre-collision) or 48 h following addition of tetracycline 
(~24 h post collision). Fixed cells were stained with phalloidin (red). Images are 
maximum projections of z stacks. (F) Confocal images of cell confrontation assays of 
GFP-RasV12 cells colliding with normal cells (R:N). Cells were fixed at 19 h (~2 h 
pre collision), 29 h (~7 h post collision), and 45 h (~23 h post collision) and stained 
with phalloidin (red) and anti-EphA2 (grey). Images are maximum projections of z 
stacks. (G) Quantification of GFP-RasV12 cell area (µm2) in cell confrontation assays 
with normal cells in the presence of various inhibitors. White bar: DMSO (n = 363 
cells); Black bar: PP2 (SFK inhibitor; n = 279 cells); Grey bar: Blebbistatin (myosin-
II inhibitor; n = 503 cells); Light grey bar: U0126 (MEK/ERK inhibitor; n = 305 
cells). Data represent mean ± s.e.m from three independent experiments; *** p < 
0.001. (H) Quantification of distance (µm) travelled by marginal GFP-RasV12 cells 
following collision with normal cells until the end of the experiment (42 h) in the 
presence of various small molecule inhibitors. White bar: DMSO; Black bar: PP2; 
Light grey bar: U0126; Hatched grey bar: ML-7 (Myosin light chain kinase inhibitor; 
Dark grey bar: Blebbistatin; Striped bar: Y27632 (ROCK inhibitor). Data indicate 
mean ± standard deviation (s.d.) from at least three independent experiments; * p < 
0.05 for DMSO versus PP2, U0126. (I) Confocal images of cell confrontation assays. 
Upper panels: GFP-RasV12 cell sheets confronting normal cells (R:N); Lower panels: 
GFP-RasV12 cells confronting GFP-RasV12 cells (R:R). Cells were fixed 41 h after 
addition of doxycycline (~17-19 h post collision) and stained with anti-
phosphorylated myosin light chain (pMLC; grey) and phalloidin (red). Images are 
maximum projections of z stacks. Scale bar, 20 µm (E, F, I). Scale bar, 50 µm (B-C). 
  
!
Figure S2. Exploring the functional role of EphA2 in GFP-RasV12 cell clustering 
and segregation. Related to Figure 2 and Figure 4. 
(A) RT-PCR analyses of EphA1, EphA2, EphA3, ephrin-A1 and ephrin-A4 mRNA 
from normal MDCK (lane 2) or GFP-RasV12 cells (lane 3) treated with tetracycline 
for 16 h (+Tet). Expression of actin mRNA from both cell lines was included as 
positive control (bottom panel). PCR reaction in the absence of cDNA template was 
included as negative control (lane 1). (B) Tetracycline-induced expression of GFP-
RasV12 and EphA2 protein in MDCK cell lines as determined by Western blotting 
using anti-GFP and anti-EphA2 antibodies, respectively. Lysates were isolated from 
cells following 24 h of tetracycline induction, and in the presence or absence of the 
MEK/ERK inhibitor U0126 for 24 h. GAPDH protein was detected using anti-
GAPDH antibodies and included as loading control. (C) Quantification of distance 
(µm) travelled by marginal GFP-RasV12 cells in cell confrontation assays with 
normal cells (not depicted). Assays were performed in the presence of 2 µg ml-1 
soluble recombinant Fc (white bar), ephrin-B-Fc (blue bars) or ephrin-A-Fc (grey 
bars) proteins. Distance was measured from collision with normal cells until the end 
of the experiment (42 h). Data indicate mean ± s.e.m. from a minimum of three 
independent experiments; ** p = 0.005; * p < 0.05 for Fc versus all other conditions. 
Addition of ephrin-B-Fc ligands yielded no significant difference compared to Fc 
controls. (D) Quantification of RasV12 cell area (µm2) in cell confrontation assays 
with normal cells in the presence of soluble recombinant Fc proteins. White bar: + Fc 
(n = 828 cells); Black bar: + ephrin-A1-Fc (n = 534 cells); Grey bar: + ephrin-A4-Fc 
(n = 317 cells). Data represent mean ± s.e.m. from three independent experiments; 
*** p < 0.001. (E) Confocal images of cell confrontation assays of GFP-RasV12 cells 
confronting normal (non-labelled) MDCK cells. Assays were performed in the 
presence of 2 µg ml-1 soluble recombinant Fc protein (upper panels), ephrin-A1-Fc 
(middle panels), or ephrin-A4-Fc (lower panels). Cells were fixed at 24 h post 
collision and stained with anti-EphA2 antibody (grey). Dashed white line depicts 
border between GFP-RasV12 and normal cells. (F) Western blot of total cell lysates 
isolated from normal (N) or GFP-RasV12 cell lines (RasV12), 24 h after addition of 
doxycycline. Expression of ephrin-A1 or GAPDH was detected using anti-ephrin-A1 
(top panels) and anti-GAPDH (lower panels), respectively. (G) Quantification of 
ephrin-A1 levels expressed on the cell surface of normal or RasV12 cells (beads, 
white bars) relative to total ephrin-A1 protein levels (lysates, black bars) as 
determined by biotinylation and Western blotting assays (n = 5). Data comparing the 
relative level of ephrin-A1 between normal and RasV12 cells are not significant. 
Scale bar, 20 µm (E). !
Figure S3. Functional role of EphA2 and downstream signalling pathways in 
RasV12-normal cell-cell interactions. Related to Figure 2. 
(A) Confocal images of GFP-RasV12 cells mixed with normal MDCK cells at 1:100 
ratios (upper panels) and GFP-RasV12 monolayers (lower panels). Cells were fixed 
48 h after addition of doxycycline and stained with anti-EphA2 (grey) or anti-
phospho-EphA2 (pEphA2, Y594; cyan) antibodies. (B) Quantification of fold 
increase in phosphorylated EphA2 intensity detected at cell-cell contacts between 
normal cells (N:N: dark blue bar, n = 90 measurements); GFP-RasV12 and normal 
cells (R:N: light blue bar, n = 42 measurements); GFP-RasV12 cells within a cluster 
and surrounded by normal cells (R:R: patterned blue bar, n = 60 measurements). Data 
represent mean ± s.e.m. from three independent experiments; *** p < 0.001 for 
  
comparisons between N:N and R:N, or N:N and R:R. Comparisons between R:N and 
R:R were not significant (n.s.). (C) Expression levels of EphA2 protein in MDCK cell 
lines in the presence of tetracycline (+ Tet) for 24 h. Cell lysates were examined from 
normal MDCK (N), MDCK-pTR-GFP-RasV12 (RasV12), MDCK-pTR-GFP-RasV12 
constitutively expressing either EphA2 shRNA-1 or shRNA-2 (KD-1 or KD-2) or 
scramble shRNA (Scb) by Western blotting using the indicated antibodies. (D) 
Confocal images of MDCK-pTR-GFP-RasV12 cells constitutively expressing either 
scramble shRNA (upper panels) or EphA2 shRNA-1 (lower panels) mixed with 
normal MDCK cells at 1:100 ratios. Cells were fixed 48 h after addition of 
doxycycline, and stained with anti-EphA2 (grey) or anti-phosphorylated Src (pSrc, 
Y416; magenta) antibodies and Hoechst (blue). (E) Confocal images of a monolayer 
of GFP-RasV12 cells fixed 48 h after addition of doxycycline and stained with anti-
EphA2 (grey) or anti-phosphorylated Src (pSrc, Y416; magenta) antibodies. (F) XZ 
orthogonal views of z-stacks as in (D) (left, central panels) or of GFP-RasV12 
monolayers (RasV12 cells only; right panels), stained with anti-EphA2 (grey) and 
either anti-phospho-EphA2 (pEphA2, Y594; cyan) or anti-phosphorylated Src (pSrc, 
Y416; magenta) antibodies and Hoechst (blue). (G) Confocal images of cell 
confrontation assays of GFP-RasV12 cells expressing EphA2 shRNA-1 confronting 
normal cells (Ras+EphA2 shRNA-1:Normal). Cells were fixed 41 h after addition of 
doxycycline (~17-19 h post collision) and stained with anti-phosphorylated myosin 
light chain (pMLC; grey) and phalloidin (red). Images are maximum projections of z 
stacks. Scale bar, 20 µm (A, D-G).  
 
Figure S4. Elevated expression of Eph receptors are functionally required to 
promote transformed cell extrusion in vitro and in vivo. Related to Figure 4. 
(A) Quantification of fold change in Drosophila DEph expression at the mRNA level 
in imaginal discs isolated from transgenic flies expressing one of four RNAi 
constructs (GLO1189, HMS0139, KK101831, GD2535) compared to wild-type.   
Data represent means ± s.d., n = 3 technical replicates on RNA pooled from several 
individual larvae. ** p < 0.01, * p < 0.05 for wild-type levels versus expression of 
RNAi. All other comparisons were not significant. (B) Confocal images of 
Drosophila wing imaginal discs expressing UAS-GFP (green, left panels) and either 
UAS-DEphRNAi-GD2535 (upper panel) or UAS-DEphRNAi-KK101831 (lower panel), 
stained for DEph protein expression using an endogenously tagged DEph:V5 
transgene (red, right panels). Area within the broken white lines shows that 
expression of each RNAi construct induced a reduction in DEph staining. Posterior is 
to the right and dorsal to the top. (C) Confocal images of Drosophila wing imaginal 
discs harbouring clones co-expressing GFP and RasV12 and two RNAi constructs 
(GD2535, KK101831). Epithelial tissues were incubated with soluble Dephrin-Fc 
protein before being fixed and stained with anti-Fc antibody (grey) and Hoescht 
(blue). White arrowheads indicate rearrangement of nuclei indicative of cyst-like 
clusters. White arrows indicate Dephrin-Fc staining in contractile RasV12 cells, 
indicating incomplete knockdown of DEph. (D) Quantification of apical extrusion of 
normal cells seeded on collagen gels and transiently transfected with DNA constructs. 
Black bar: GFP-RasV12 and pcDNA (n = 355 cells); White bar: GFP-RasV12 and 
HA-tagged EphA2 deltaC (+EphA2 DN; n = 362 cells); Dark grey bar: GFP-tagged 
v-Src (Src Y576F) and pcDNA (n = 238 cells); Light grey bar: GFP-tagged v-Src and 
HA-tagged EphA2 deltaC (+EphA2 DN; n = 226 cells). Co-expression of HA-tagged 
EphA2 deltaC (EphA2 DN) and GFP, or pcDNA vector and GFP (pcDNA control) 
did not induce apical extrusion of cells. Cells were fixed 24 h after transfection. Data 
  
represent mean ± s.e.m. from three independent experiments, except HA + GFP 
(pcDNA control), n = two experiments. * p < 0.05 for comparisons between v-Src 
versus v-Src + EphA2 DN and RasV12 versus RasV12 + EphA2 DN. (E) Model 
showing that (1) cell-cell interactions between sheets of RasV12 (green) and normal 
epithelial cells triggers EphA2-ephrin-A signals at the RasV12:Normal cell-cell 
interface. (2) This activates EphA2 receptor (pEphA2) expressed on RasV12 cells and 
SFK (pSrc) to modulate RasV12 cell shape and myosin-II-dependent contractility. 
Subsequently, (3) neighbouring RasV12 cells that are positioned behind marginal 
cells and not in direct contact with normal cells are triggered to contract in an EphA2-
dependent manner. A combination of the initial repulsion signal and the concomitant 
contractility, promotes the segregation of RasV12 cells from normal cells. Scale bar, 
20 µm (B-C).  
 !!
Supplemental Movies S1; Related to Figure 1 and Figure S1. 
Representative time-lapse experiment of cell confrontation assays of non-labelled 
normal cells colliding with GFP-RasV12 cells as depicted in Figure 1A (left panels). 
Movie is a composite of bright field images and fluorescence images captured at 488 
nm (GFP). Duration is 30 h. 
 
Supplemental Movies S2; Related to Figure 1 and Figure S1. 
Representative time-lapse experiment of cell confrontation assays of GFP-RasV12 
cells colliding with GFP-RasV12 cells as depicted in Figure 1A (right panels). Movie 
is a composite of bright field images and fluorescence images captured at 488 nm 
(GFP) and 568 nm (CMTPX tracker dye), which are shown every 10 h. Duration is 30 
h. 
 
Supplemental Movies S3; Related to Figure 1 and Figure S1. 
Combined movies of individual trajectories of 10 cells tracked post-collision in cell 
confrontation assays. Movie on the left shows GFP-RasV12 cells colliding with GFP-
RasV12 cells, as depicted in Figure S1C (lower panels). One population of GFP-
RasV12 cells was prestained with cell tracker dye in order to demarcate the collision 
interface. Movie on the right shows non-labelled normal cells colliding with GFP-
RasV12 cells, as depicted in Figure S1C (upper panels). Numbered end of track 
indicates direction of cell movement. Cells were tracked over 15 h. 
 
Supplemental Movies S4; Related to Figure 1 and Figure S1. 
Representative time-lapse experiment of cell confrontation assays of non-labelled 
normal cells (left) colliding with non-labelled RasV12 cells (right) in the presence of 
blebbistatin (25µM). Fluorescence images were not captured, as blebbistatin is blue 
light sensitive. Inhibitor was added approximately 30 min prior to recording. Duration 
is 30 h.  
 
 Supplemental materials and methods 
Antibodies, Plasmids and Reagents 
Primary antibodies used: Rat anti-E-cadherin (ECCD2) (Life technologies); rabbit anti-phospho-EphA2 
(Y594) (p-EphA2), rabbit anti-phospho-Src (Y416) (p-Src), rabbit anti-phospho-myosin light chain (pMLC), 
all from Cell Signaling Technology; anti-GAPDH (Chemicon International); mouse anti-EphA2 (clone D7) 
(Millipore) or rabbit anti-EphA2 (Santa-Cruz); rabbit anti-ephrin-A1 (Abcam); mouse anti-GFP (Roche). 
Secondary antibodies (Alexa-405-, Alexa-568-, Alexa-546- and Alexa-647-conjugated anti-rat, anti-mouse 
and anti-rabbit) were from Life Technologies. DNA plasmids used include: pcDNA3.1-HA (kindly provided 
by M. Razi, The Francis Crick Institute, London), pShuttle-HA-EphA2 deltaC (generously provided by N. 
Mochizuki, National Cerebral and Cardiovascular Center Research Institute, Japan), pcDNA4/T0/GFP-
SrcY574F and pcDNA4/T0/GFP were constructed as previously described SS1, S2]. (S)-(-)-blebbistatin 
(Tocris Bioscience) was used at 25 µM; U0126 from Promega was used at 10 µM; PP2, ML-7 and Y27632 
were from Millipore (Calbiochem) and were used at 10 µM. All inhibitors were added to cell confrontation 
assays at collision, or ~1 h prior to collision until the end of the experiment (42 h). DMSO (Sigma-Aldrich) 
was added at a dilution of 1:1,000 as control.  
 
Cell culture and RNA interference 
Normal MDCK cells, MDCK-pTR cell lines stably expressing GFP-RasV12 in a Tet-ON inducible manner 
or E-cadherin shRNA were cultured as previously described [S1]. MDCK-pTR-GFP-RasV12 cell lines 
constitutively expressing EphA2 shRNA were produced using EphA2 shRNA oligonucleotides (EphA2 
shRNA-1: 5’-
GATCCCCGTCTAACAGGGACAAAGAATTCAAAGAGATTCTTTGTCCCTGTTAGACTTTTTC-3’; 
EphA2 shRNA-2: 5’- 
GATCCCCGCAGCAAGATTCACGAGTTTTCAAGAGAAACTCGTGAATCTTGCTGCTTTTTC-3’). 
Scramble shRNA oligonucleotides were designed as previously described [S3]. EphA2 or scramble shRNA 
were cloned into BglI and XhoI sites of pSUPER.neo+gfp (Oligoengine, Seattle, WA). MDCK-pTR-GFP-
RasV12 cells were transfected with pSUPER.neo+gfp EphA2 or scramble shRNA using Lipofectamine 2000 
(Life Technologies), followed by selection in medium containing 800 µg ml-1 of G418 (Calbiochem). More 
than two stable clones were obtained for two independent shRNA oligonucleotides. Depletion of EphA2 was 
analysed by immunofluorescence and Western blotting following 24 h incubation with tetracycline or 
doxycycline (2 µg ml-1). Comparable effect of EphA2 depletion on segregation, cell repulsion or apical 
extrusion was observed in cells expressing EphA2 shRNA-1 or -2. Cells were plated as described below, 
except where indicated as low-density; cells were plated at 1 x 103 cells in 4-well culture dishes (Nunc, 
Roskilde, Denmark).  
 
Coculture assays, Cell confrontation assays and Time-lapse microscopy 
MDCK-pTR-GFP-RasV12 cells were trypsinised and mixed with non-labelled normal MDCK cells at a ratio 
of 1:100. Cells were plated at a density of 4 x 105 on 13 mm serum-coated glass coverslips. Mixed cells were 
incubated for 8-16 h at 37oC before being switched to tetracycline/doxycycline-containing medium. Cell 
confrontation assays were set up using commercially available cell culture inserts (Ibidi GmbH) according to 
manufacturer’s instructions. Briefly, MDCK-pTR-GFP-RasV12, MDCK-pTR-GFP, or normal MDCK cells 
were seeded into one of two compartments, at a density of 3-4 x 104 cells. Cells were incubated for 8-16 h at 
37oC before removal of the culture insert and switched to tetracycline/doxycycline-containing medium. Cell 
sheets were allowed to collide before addition of inhibitors or unclustered Fc proteins. In order to monitor 
cell morphology changes over time, we fixed cells at different time points post collision. Generally, we 
observed repulsion of RasV12 cells in the first 5 rows from the cell margin at 30-40 h (e.g., Figure 1D, 1G), 
and repulsion of RasV12 cells beyond rows 1-5 at 48 h (e.g., Figure S1E) post treatment with 
tetracycline/doxycycline. In order to capture differences in RasV12 cell morphology; e.g., in marginal cells 
 immediately post collision, or in the cell sheet at later time points, we monitored cells over time and fixed 
cells when RasV12 cell changes were observed. To obtain time-lapse images, we used a Zeiss Axiovert 
200M microscope with a Ludl Electronic Products Biopoint Controller and a Hamamatsu C4742-95 Orca 
camera (Hamamatsu) or a Leica automated inverted DMI6000B microscope system with Leica DFC365FX 
camera. Images were captured using Volocity (Improvision) or Leica Application Suite (LAS) image 
analysis software (v3.2.0). Data in Figure 1B, S1G were analysed using Metamorph 6.0 digital analysis 
software (Universal Imaging), and in Figure 2D, S2C using LAS (Leica) image analysis software. Single-cell 
tracking of cells in the confrontation assay was performed using the manual tracking plugin in Fiji (National 
Institute of Health) (v1.48j) software. Cells in rows 1-5 and rows 5-10 were demarcated at collision and their 
subsequent positions were manually recorded every 10 frames (100 minutes) for 15 h post-collision. 
  
Collagen assays  
To quantify apical extrusion, co-culture experiments were carried out on type I collagen gels (Nitta Gelatin) 
as previously described [S1]. Briefly, cells were plated at a total of 1 x 106 cells per 35-mm well where GFP-
RasV12 cells were mixed with normal cells at ratios of 1:100. Cells were incubated for 8-16 h at 37oC before 
inducing GFP-RasV12 expression with tetracycline/doxycycline. Cells were fixed 24 h later and stained as 
previously described [S1].  
For transient expression experiments, normal MDCK cells were first seeded on collagen I gels at a density of 
7 x 105 per 35-mm well. On the following day, cells were transiently transfected with the indicated DNA 
constructs using LipofectamineTM 3000 according to manufacturer’s instructions (at 2 µg per construct). 
Cells were fixed at the indicated time points and stained as previously described [S1]. Apical extrusion was 
scored as previously described [S1]. Briefly, apical extrusion was scored when single or small clusters of 
cells (3-5 cells) were eliminated from the apical side of the epithelial cell sheet.  
 
Recombinant Fc- protein treatment of cell lines 
Recombinant ephrin-A-Fc or ephrin-B-Fc ligands were from R&D systems and recombinant Fc proteins 
from Millipore. For inhibition of Eph-ephrin signalling experiments, unclustered ephrin-A-Fc, ephrin-B-Fc 
or Fc proteins were added to cell confrontation assays at cell collision at 2 µg ml-1. Recombinant ephrin-A1-
Fc or ephrin-A4-Fc fusion proteins were pre-clustered with anti-human Fc antibodies at a 2:1 molar ratio and 
added to MDCK-pTR-GFP-RasV12 cells, or MDCK-pTR-GFP-RasV12 cells expressing EphA2 (or 
scramble) shRNA at a final concentration of 10 µg ml-1. Cells were incubated for 24 h before fixing. For 
modified stripe assays, pre-clustered ephrin-A1-Fc, ephrin-A4 or Fc proteins (10 µg ml-1) were added to one 
compartment of the culture insert used in cell confrontation assays. Stripes of pre-clustered Fc proteins were 
incubated at 37oC for 30 min and washed once with PBS. Fc stripes were visualised with anti-Fc antibodies 
(Jackson labs) and fluorescence. Normal MDCK, MDCK-pTR-GFP-RasV12 cell lines or MDCK-pTR-GFP-
RasV12 cells constitutively expressing EphA2 shRNA or scramble shRNA, were seeded in the second 
compartment. Cells were incubated for 8-16 h at 37oC before removal of the culture insert and switched to 
tetracycline/doxycycline-containing medium. All RasV12 cell lines were fixed and analysed 72 h later. 
Normal cells were fixed and analysed at 96 h. 
 
Immunofluorescence 
Immunofluorescence of cells cultured on serum-coated glass coverslips was performed as previously 
described [S4], except for experiments using anti-phospho-specific antibodies; here the protocol was 
modified to include 1X TBS with 1 mM NaF, 1 mM Na3VO4 in all washing and blocking steps. All primary 
antibodies were used at a dilution of 1:100 except p-EphA2 (Y594), p-MLC and p-Src (Y416) antibodies, 
which were used at 1:50. All secondary antibodies were used at 1:200-1:400 dilutions. TRITC-phalloidin 
(Sigma-Aldrich) was used at 1.5 µg ml-1. In some experiments, GFP-RasV12 cells were prestained with a 
cell tracker dye as previously described [S1] (Red: CMTPX or Orange: CMRA; both from Life 
 Technologies). Cells cultured on glass coverslips were examined using either a Leica TCS SPE confocal 
microscope, Leica DMI600B inverted epifluorescence microscope with a Leica DFC365FX camera, or Zeiss 
LSM710 confocal microscope. Images were analysed using LAS software (v3.2.0), Zen (Zeiss Efficient 
Navigation) software, or Fiji (National Institute of Health) (v1.48j) software. 
 
Quantitative image analysis 
Inter-nuclear distance (IND) was calculated by measuring the distance between the centre of nuclei of 
neighbouring cells in direct contact in GFP-labelled cell clusters in 1:100 co-culture assays. Measurements 
were made by first using point-picker in Fiji (v1.48j) to demarcate the centre points of nuclei, followed by 
Voronoi analysis using custom scripts in Python (v3.3) to measure the distance between these centre points 
from a minimum of three repeated experiments. To analyse the cell area in confrontation assays, single z-
stack slices were converted to 8-bit grayscale images in Fiji (v1.48j) and segmented using Packing Analyzer 
(v2.0) [S8]. The flood area feature in Packing Analyzer was used to give total cell areas in pixels, which 
were then converted to areas in µm2 using metadata. Cells in the y-axis in direct contact with the opposing 
cell sheet were demarcated as row 1 and subsequent cells behind as row 2, row 3 etc. based on their position 
in the x-axis relative to row 1 cells. The number of rows available for quantification in rows 11+ varied 
between confrontation assays and was determined by field of view but generally extended to row 14. A 
minimum of 14 cells were analysed per subset of rows. To measure the coefficient of boundary smoothness 
between interacting cell sheets in the cell confrontation assay, we performed analysis as previously described 
[S5]. 
 
PI-PLC treatment, Biotinylation assays and Immunoblotting 
Endogenous ephrin-A ligands were cleaved from the cell surface of normal cells as previously described 
[S6]. Briefly, cells were pre-treated with 1 U ml-1 PI-PLC (Life Technologies), or an equivalent volume of 
PBS for 4 h before being switched back to regular DMEM/FCS media. Untreated controls were also 
included. Cells were then trypsinised and used in 1:100 co-culture assays. Cell lysates were also harvested at 
4 h or 28 h post-treatment.  
To detect ephrin-A1 expressed at the cell surface of normal or GFP-RasV12 cell lines, we performed 
biotinylation assays as previously described [S7]. Briefly, sub-confluent MDCK cells were placed on ice and 
washed twice in ice cold PBS. Cells were then incubated with 1 mg ml-1 EZ-link SulfoNHS-SS-biotin 
(Pierce/Thermo Scientific) in PBS for 30 min at 4°C followed by one wash with cold PBS and incubation in 
quenching buffer (50 mM NH4Cl in PBS containing 1 mM MgCl2 and 0.1 mM CaCl2) for 5 min at 4°C. The 
cells were then lysed in RIPA buffer (20 mM Tris-HCl pH 7.4, with 150 mM NaCl, 0.1% SDS, 1% Triton 
X-100, 1% deoxycholate, 5 mM EDTA) plus protease inhibitors. Lysates were centrifuged to obtain a 
detergent-soluble supernatant, which was incubated with streptavidin (Neutravidin) beads (Pierce/Thermo 
Scientific) for 1 h, rotating at 4oC to collect bound, biotinylated proteins. Samples were then analyzed by 
SDS-PAGE and immunoblotting to identify ephrin-A1. Immunoblotting analyses were performed using the 
following antibodies: rabbit anti-EphA2 (Santa Cruz), mouse anti-GFP (Roche) at 1:1,000, mouse anti-
GAPDH (Chemicon International) at 1:5,000, rabbit anti-ephrin-A1 (Abcam) at 1:500. Secondary HRP-
conjugated antibodies were from Sigma; ECL reagent from Pierce. Immunoblots were developed and band 
intensity quantified using a Biorad Gel-doc system. 
 
Expression and purification of recombinant Fc proteins  
pCEP4 Dephrin-Fc and pCEP4 Fc plasmids were kindly provided by Philip F. Copenhaver (Oregon Health 
& Science University). HEK293 cells (grown in DMEM, 10% FCS, 1% penicillin/streptomycin, 1% 
glutamax) were seeded in 15-cm dishes and allowed to reach 70% confluence, before being transfected with 
pCEP4 plasmids using Lipofectamine 3000 (Life technologies). The next day, cells were switched to serum-
free media (DMEM plus 1% penicillin/streptomycin, 1% glutamax), and cultured for 6 days. Protein was 
purified as previously described [S8, S9]. Briefly, the pH of the conditioned media was adjusted to pH 8.0 
 before incubating with protein A sepharose beads (Sigma) and collected using affinity chromatography 
(Pierce). Beads were washed three times with 100 mM Tris Cl, pH 8.0, followed by elution using 100 mM 
glycine, pH 3.0 and collected into 1 M Tris Cl, pH 8.0. Pooled fractions were dialyzed against sterile PBS 
(pH 7.4) and stored at 4oC. Fc protein integrity was assessed by coomassie blue staining of polyacrylamide 
gels and concentrations were determined using Nanodrop spectroscopy. We were unable to purify adequate 
quantities of Fc protein using this method; therefore commercial Fc protein was used as a control in 
experiments using Drosophila wing imaginal discs.  
 
Generation and analyses of GFP and RasV12 overexpressing clones in Drosophila melanogaster wing 
imaginal discs 
Drosophila larvae were reared on standard cornmeal medium, at 25ºC unless otherwise indicated. GFP-
labelled clones were induced 72-96 h after egg laying (AEL) by heat treatment at 35ºC for 10 min, and wing 
imaginal discs were dissected two days later. Experimental larvae were obtained by crossing hs-FLP1.22; 
Act5C-FRT-y[+]-FRT-Gal4, UAS-GFP flies with UAS-RasV12, or UAS-Dcr2; UAS-RasV12, 
UAS-DEphRNAiKK101831; UAS-DEphRNAiGD2535 [S10], or UAS-RasV12; UAS-DEphDN flies [S11]. DEph 
receptor was detected using purified Dephrin-Fc, as previously described [S6]. Fc proteins were detected 
using goat anti-human Fc (Sigma). To test the relative efficiency of different RNAi constructs, first we raised 
hs-FLP1.22; UAS-DEphRNAi / UAS-GFP; Act5C-FRT-y[+]-FRT-Gal4SwitchPR flies, induced ubiquitous 
recombination by heat shock treatment (60 min at 37ºC) at 72-96 h AEL and immediately afterwards, 
Mifepristone was added (Sigma, 500µg per vial) to activate the Gal4SwitchPR transcriptional regulator. 
Total RNA was extracted from larvae two days later, on which qRT-PCR analysis was performed using the 
primers 5’-TGGAACTGGTCAAATCAGGACGTG-3’ and 5’-ATCCATCGGAGCTGGTAAACGG-3’ with 
SYBR Green Master Mix reagent on a QuantStudio 7 Flex instrument (Life Technologies). We then raised 
UAS-Dcr2; ptc-Gal4, UAS-GFP / UAS-DEphRNAi; DEph:V5 (DEph:V5 is a transgene from the fly-
TransgeneOme collection, inserted on the 3rd chromosome, comprising the full genomic region of the DEph 
gene, and tagged with 2XTY1-SGFP-V5-preTEV-BLRP-3XFLAG [S12]) flies at 29ºC and tested each 
RNAi for DEph expression in the wing pouch of 3rd instar larvae with anti-V5 (R960-25, Invitrogen). 
Secondary antibodies were donkey anti-goat and goat anti-mouse conjugated to Alexa568 (Life 
Technologies). Discs were examined and imaged using a Zeiss LSM710 confocal microscope; images were 
analysed using Fiji (v1.48j). Segregating clones were scored in the wing pouch only, consistent with our 
previous study [S1]. 
 
Statistical analyses 
All data were plotted in Prism 6 (Graphpad). Error bars on graphs represent mean ± standard error of the 
mean (s.e.m.) except for Figure 1B, Figure S1G and Figure S2C; here error bars on graphs represent mean ± 
standard deviation of the mean (s.d.). To test for statistical significance between experimental groups, one-
way ANOVAs were performed with a Dunn’s post-hoc test; except for time-lapse data depicted in Figure 1B 
and data comparing differences in cell area, which were analysed using two-tailed parametric t-tests (with or 
without Welch’s correction). Two-tailed non-parametric t-tests (Mann-Whitney) were used for Figure S4D. 
P-values of < 0.05 were taken as significant. 
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